原发性肝癌的治疗决策

Therapeutic strategy for hepatocellular carcinoma

原发性肝癌的病因主要是乙肝病毒及丙肝病毒,绝大多数肝癌患者合并有肝硬化.治疗手段的选择取决于肿瘤位置,转移及肝脏储备功能等因素.在合适的患者中,原发性肝癌首选治疗为肝切除术或肝移植.对不可手术的肝癌,则可选择局部消融治疗或肝动脉栓塞化疗.更晚期的患者只能作对症治疗.治疗选择的标准需以临床实验研究为基础.

Hepatitis B or C virus infection carries a high risk for genesis of hepatocellular cato_noma （HCC）. Most of HCC patients were complicated with cirrhosis. The choice of therapeutic modality is depended on tumor location, metastasis and liver function. The only proven potentially curative therapy for HCC are hepatic resection or liver transplantation in highly selected patients. For the patients with non- resectable HCC, chemoembolization and ablation therapy may be used as the primary therapy. Agents for highly advanced HCC should be given based on clinical trials.